The combination of BET-Bromodomain inhibitor JQ1 and small molecule inhibitor ABT-263 inhibited MYC protein levels and MYC-driven miR-1271-5p expression, and induced CRC cell apoptosis through PMAIP1/MCL1 pathway [89]. This evidence concerns the gene MYC and colorectal carcinoma.